Complete stable remission after extended transsternal thymectomy in myasthenia gravis

European Journal of Cardio-thoracic Surgery

Volumn 30, Issue 3, 2006, Pages 525-528

  Park, In Kyu ^a   Choi, Sung Sil ^b   Lee, Jin Gu ^a   Kim, Dae Joon ^a   Chung, Kyung Young ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Jaesaeng Hospital   (South Korea)

Author keywords

Complete stable remission; Extended transsternal thymectomy; Myasthenia gravis

Indexed keywords

STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; EXTENDED TRANSSTERNAL THYMECTOMY; FEMALE; HAZARD ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MYASTHENIA GRAVIS; PRIORITY JOURNAL; PROGNOSIS; REMISSION; RETROSPECTIVE STUDY; SCHOOL CHILD; STATISTICAL SIGNIFICANCE; STEROID THERAPY; SURGICAL TECHNIQUE; THYMECTOMY; THYMOMA; TIME SERIES ANALYSIS;

EID: 33746894138     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.06.009     Document Type: Article

References (19)

1. Richman D.P., and Agius M.A. Treatment of autoimmune myasthenia gravis. Neurology 61 (2003) 1652-1661
2. Jaretzki A. Thymectomy for myasthenia gravis: analysis of controversies - patient management. Neurologist 9 (2003) 77-92
3. Jaretzki A., Barohn R.J., Ernstoff R.M., Kaminski H.J., Keesey J.C., Penn A.S., and Sanders D.B. Myasthenia gravis: recommendations for clinical research standards. Ann Thorac Surg 70 (2000) 327-334
4. Masaoka A., Yamakawa Y., Niwa H., Fukai I., Kondo S., Kobayashi M., Fujii Y., and Monden Y. Extended thymectomy for myasthenia gravis patients: a 20-year review. Ann Thorac Surg 62 (1996) 853-859
5. Nieto I.P., Robledo J.P.P., Pajuelo M.C., Montes J.A.R., Giron J.G., Alonso J.G., and Sancho L.G. Prognostic factors for myasthenia gravis treated by thymectomy: review of 61 cases. Ann Thorac Surg 67 (1999) 1568-1571
6. Masaoka A., Monden Y., Nakahara K., and Tanioka T. Follow up study of thymomas with special reference to their clinical stages. Cancer 48 (1981) 2485-2492
7. Gronseth G.S., and Barohn R.J. Practice parameter: thymectomy for autoimmune myasthenia gravis (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 55 1 (2000) 7-15
8. Scott W., and Detterbeck F. Transsternal thymectomy for myasthenia gravis. Semin Thorac Cardiovasc Surg 11 (1999) 54-58
9. Mantegazza R., Baggi F., Bernasconi P., Antozzi C., Confalonieri P., Novellino L., Spinelli L., Ferrò M.T., Beghi E., and Cornelio F. Video-assisted thoracoscopic extended thymectomy and extended transsternal thymectomy in non-thymomatous myasthenia gravis patients: remission after 6 years of follow-up. J Neurol Sci 212 (2003) 31-36
10. Venuta F., Rendina E.A., Giacomo T.D., Rocca G.D., Antonini G., Ciccone A.M., Ricci C., and Coloni G.F. Thymectomy for myasthenia gravis: a 27-year experience. Eur J Cardiothorac Surg 15 (1999) 621-625
11. López-cano M., Ponseti-Bosh J.M., Espin-Basany E., Sánchez-García J.L., and Armengol-Carrasco M. Clinical and pathologic predictors of outcome in thymoma-associated myasthenia gravis. Ann Thorac Surg 76 (2003) 1643-1649
12. Budde J.M., Morris C.D., Gal A.A., Mansour K.A., and Miller J.I. Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg 72 (2001) 197-202
13. Mantegazza R., Baggi F., Antozzi C., Confalonieri P., Morandi L., Bernasconi P., Andreerra F., Simoncini O., Campanella A., Beghi E., and Cornelio F. Myasthenia gravis: epidemiological data and prognostic factors. Ann N Y Acad Sci 998 (2003) 413-423
14. Romi F., Gilhus N.E., Varhaug J.E., Myking A., Skeie G.O., and Aarli J.A. Thymectomy and antimuscle autoantibodies in non-thymomatous myasthenia gravis. Ann N Y Acad Sci 998 (2003) 481-490
15. Téllez-Zenteno J.F., Remes-Troche J.M., García-Ramos G., Estañol B., and Garduño-Espinoza J. Prognostic factors of thymectomy in patients with myasthenia gravis: a cohort of 132 patients. Eur Neurol 46 (2001) 171-177
16. Watanabe A., Watanabe T., Obama T., Mawatari T., Ohsawa H., Ichimiya Y., Takahashi N., Kusajima K., and Abe T. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis. J Thorac Cardiovasc Surg 127 (2004) 868-876
17. Romi F., Gilhus N.E., Varhaug J.E., Myking A., and Aarli J.A. Disease severity and outcome in thymoma myasthenia gravis: a long-term observation study. Eur J Neurol 10 (2003) 701-706
18. Evoli A., Tonali P.A., Padua L., Monaco M.l., Scuderi F., Batocchi A.P., Marino M., and Bartoccioni E. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126 (2003) 2304-2311
19. Özdemir N., Kara M., Dikmen E., Nadir A., Akal M., Yücemen N., and Yavuzer S. Predictors of clinical outcome following extended thymectomy in myasthenia gravis. Eur J Cardiothorac Surg 23 (2003) 233-237